Before you sell to, join or invest in Aveta Biomics, Inc.
MentionFox check on Aveta Biomics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/aveta-biomics-inc-form-d-25000001
Check Aveta Biomics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Aveta Biomics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Aveta Biomics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-19.
Aveta Biomics, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 19, 2025. The filing reports $4.46M sold. Its industry group is Pharmaceuticals. It names Parag Mehta (Executive Officer, Director), S. P. Kothari (Director), Bharat Tewarie (Director) (SEC Form D, March 19, 2025).
Is this your company?
Sell to companies like Aveta Biomics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Aveta Biomics, Inc.
Free to see. No signup.
More on the people and the money behind Aveta Biomics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Aveta Biomics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Aveta Biomics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Aveta Biomics, Inc. →Get the full cited report on Aveta Biomics, Inc.
What the filing shows about Aveta Biomics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Aveta Biomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Aveta Biomics, Inc.'s address as 110 Great Road, Suite 302, Bedford, MA 01730.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Aveta Biomics, Inc. is a registered filer with the SEC (CIK 1734691) and has filed since 2025-03-19. 1 filing is on record, the latest on 2025-03-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Aveta Biomics, Inc.'s Form D of 2025-03-19 names Parag Mehta, S. P. Kothari, Bharat Tewarie and 2 more as its officers, directors or promoters.
Its new offerings report $4.46M sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Parag Mehta is named as Executive Officer and Director on the Form D that Aveta Biomics, Inc. filed with the SEC on 19 March 2025, one of 5 people that filing names.
S. P. Kothari is named as Director on the Form D that Aveta Biomics, Inc. filed with the SEC on 19 March 2025, one of 5 people that filing names.
Bharat Tewarie is named as Director on the Form D that Aveta Biomics, Inc. filed with the SEC on 19 March 2025, one of 5 people that filing names.
David Page is named as Director on the Form D that Aveta Biomics, Inc. filed with the SEC on 19 March 2025, one of 5 people that filing names.
Peter Dolan is named as Director on the Form D that Aveta Biomics, Inc. filed with the SEC on 19 March 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-03-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Aveta Biomics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Aveta Biomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aveta Biomics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Aveta Biomics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Aveta Biomics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Aveta Biomics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/aveta-biomics-inc-form-d-25000001